Novartis | NVS - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 384.69B 19.14B 2026-03
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Canopy Growth CAD 125.74M 431.39M 2026-07
Corcept Therapeutics USD 4.32B 654M 2026-03
Drreddys Laboratories INR 2.41B 8.66B 2026-07
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Glaxosmithkline GBP 108.55B 736M 2026-07
J&J USD 608.04B 28.89B 2026-07
Merck USD 297.1B 35.84B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Novartis USD 319.89B 31.63B 2026-07
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.8B 161M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Sanofi EUR 108.52B 5B 2026-07
Supernus Pharmaceuticals USD 2.98B 126M 2026-03
Zoetis USD 49.71B 5.74B 2026-03